Marianna Politou

Summary

Publications

  1. ncbi request reprint Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon-alpha
    Marianna Politou
    First Department of Internal Medicine, University of Athens Medical School, Greece
    Nephrol Dial Transplant 19:733-5. 2004
  2. ncbi request reprint Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration
    Evangelos Terpos
    Department of Haematology, Faculty of Medicine Imperial College, Hammersmith Hospital, Du Cane Road, W12 0NN London, UK
    J Cancer Res Clin Oncol 130:623-5. 2004
  3. ncbi request reprint No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib
    Marianna Politou
    Leuk Res 30:240-1. 2006
  4. ncbi request reprint Anti-angiogenic effect of bortezomib in patients with multiple myeloma
    Marianna Politou
    Department of Haematology, Faculty of Medicine Imperial College London, Hammersmith Hospital, London, UK
    Acta Haematol 114:170-3. 2005

Detail Information

Publications4

  1. ncbi request reprint Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon-alpha
    Marianna Politou
    First Department of Internal Medicine, University of Athens Medical School, Greece
    Nephrol Dial Transplant 19:733-5. 2004
  2. ncbi request reprint Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration
    Evangelos Terpos
    Department of Haematology, Faculty of Medicine Imperial College, Hammersmith Hospital, Du Cane Road, W12 0NN London, UK
    J Cancer Res Clin Oncol 130:623-5. 2004
    ..Therefore, TLS should be looked for during the first cycle of bortezomib treatment and suitable precautions should be considered...
  3. ncbi request reprint No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib
    Marianna Politou
    Leuk Res 30:240-1. 2006
  4. ncbi request reprint Anti-angiogenic effect of bortezomib in patients with multiple myeloma
    Marianna Politou
    Department of Haematology, Faculty of Medicine Imperial College London, Hammersmith Hospital, London, UK
    Acta Haematol 114:170-3. 2005